Consensus Cloud Solutions (CCSI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Q2 2026 revenue rose 4.1% year-over-year to $91.4 million, driven by 9.3% growth in the Corporate segment and a slower 4.7% decline in SoHo revenue.
Net income increased 31.7% to $27.4 million, with diluted EPS up to $1.43 and net income margin improving to 30%.
Free cash flow grew 25.1% year-over-year to $25.5 million, with $98.9 million in cash at quarter-end.
Strategic initiatives included the formation of a Healthcare Strategy and Solutions Group and the acquisition of doc.health/Dock Health to expand non-fax healthcare solutions.
The share repurchase program was expanded to $200 million, with $118 million remaining and 3 million shares repurchased to date.
Financial highlights
Corporate revenue reached $60.5 million, up 9.3% year-over-year, with ARPA at $305 and customer base up 9.4% to 67,000.
SoHo revenue was $30.9 million, declining 4.7% year-over-year, with ARPA at $16.06 and 637,000 accounts.
Adjusted EBITDA was $48.3 million (52.9% margin), and adjusted net income was $28.7 million.
Adjusted EPS rose to $1.49, aided by share repurchases.
Gross margin was 80%, and net margin was 30%.
Outlook and guidance
FY 2026 revenue guidance reaffirmed at $350–$364 million, with adjusted EBITDA of $182–$193 million and adjusted EPS of $5.55–$5.95.
Q3 2026 guidance: revenue $89.2–$93.2 million, adjusted EBITDA $45–$48 million, adjusted EPS $1.34–$1.44.
doc.health acquisition expected to contribute $1 million in revenue and a $0.6 million negative EBITDA impact for the year.
Management expects continued organic and inorganic growth, with capital allocated to reinvestment and opportunistic acquisitions.
Latest events from Consensus Cloud Solutions
- All proposals passed, directors elected, and no stockholder questions were received.CCSI
AGM 2026 - Q1 2026 revenue up 1.5%, net income and cash flow rose, driven by Corporate growth.CCSI
Q1 2026 - Board recommends approval of all four proposals, highlighting governance and ESG focus.CCSI
Proxy filing - Virtual annual meeting to vote on directors, auditor, executive pay, and stock plan amendments.CCSI
Proxy filing - Corporate growth, record cash flow, and buybacks drive strong results and positive 2026 outlook.CCSI
Q4 2025 - Net income and margins rose in Q2 2024 despite lower revenue and continued SoHo weakness.CCSI
Q2 2024 - Healthcare interoperability, AI, and capital returns drive growth and margin improvement.CCSI
Jefferies Global Healthcare Conference - Healthcare solutions and recurring revenue drive growth as FY2024 guidance is reaffirmed.CCSI
Goldman Sachs 45th Annual Global Healthcare Conference - Corporate growth, margin strength, and record free cash flow offset SoHo declines in 2024.CCSI
Q4 2024